Etiology

Pathogens

  • Escherichia coli: leading cause of UTI (approx. 80%)
    • Ten times more common in females (shorter urethras colonized by fecal microbiota).
  • Staphylococcus saprophyticus: 2nd leading cause of UTI in sexually active women
  • Klebsiella pneumoniae: 3rd leading cause of UTI
  • Proteus mirabilis
    • Produces ammonia, giving the urine a pungent or irritating smell
    • Associated with struvite stone formation
  • Nosocomial bacteria: Serratia marcescens, Enterococci spp., and Pseudomonas aeruginosa are associated with increased drug resistance.

Tip

  • Urethritis is often caused by sexually transmitted infections (STIs), e.g. N gonorrhoeae.
  • UTIs are generally caused by bacteria from the gastrointestinal tract, e.g. E coli.

Pathophysiology


Clinical features


Diagnostics

Urinalysis

  • Pyuria: presence of white blood cells (WBCs) in the urine
    • Positive leukocyte esterase: an enzyme produced by WBC
    • ≥ 5 WBC/HPF
  • Bacteriuria: presence of bacteria in the urine
    • Positive urinary nitrites: indicate bacteria that convert nitrates to nitrites (most commonly gram-negative bacteria; e.g., E.coli, Klebsiella, Proteus mirabilis)
  • Other findings
    • Leukocyte casts may indicate pyelonephritis.
    • Micro- or macroscopic hematuria may be present.
    • Alkaline urine (pH > 8) and struvite crystals in sediment: indicate urease-producing organisms (e.g., Proteus, Klebsiella, Staphylococcus saprophyticus)

Treatment


UTI in pregnancy


  • Pregnancy may increase the risk of recurrent bacteriuria and UTIs.
  • Treatment
    • Empiric antibiotics for ASB and lower UTI considered appropriate during pregnancy include:
      • Fosfomycin
      • Beta-lactam antibiotics for 5–7 days
        • Oral cephalosporins (e.g., cefpodoxime)
        • Aminopenicillins plus beta-lactamase inhibitors (e.g., amoxicillin/clavulanic acid)

Catheter-associated UTI (CAUTI)


  • Definitions
    • Catheter-associated UTI (CAUTI): symptomatic UTI occurring in a patient with an indwelling urinary catheter OR within 48 hours after removal of a urinary catheter
    • Catheter-associated asymptomatic bacteriuria (CAASB): bacteriuria (≥ 105CFU/mL) without symptoms in a patient with an indwelling urinary catheter OR within 48 hours after removal of a urinary catheter
  • Treatment
    • Catheter removal or replacement
      • Remove if no longer necessary.
      • Replace if still necessary and present for > 2 weeks.
    • Antibiotic therapy
      • Guided by culture results and local resistance patterns
      • Duration: typically 7–14 days depending on the resolution of symptoms